Pulmonx Corp (FRA:4NI)
€ 1.76 +0.080 (+4.79%) Market Cap: 85.11 Mil Enterprise Value: 85.43 Mil PE Ratio: 0 PB Ratio: 2.51 GF Score: 62/100

Q2 2026 Pulmonx Corp Earnings Call Transcript

Jul 29, 2026 / 08:30PM GMT
Release Date Price: €1.07 (+2.88%)
Operator

Ladies and gentlemen, thank you for standing by. Welcome to Pulmonx's second quarter 2026 earnings conference call. (Operator Instructions) Please be reminded that today's conference is being recorded.

I would like now to turn the call over to Webb Campbell, Investor Relations. Please go ahead.

Webb Campbell
Pulmonx Corp - Investor Relations

Good afternoon and thank you for joining today's call. Joining me from Pulmonx are Glen French, President and Chief Executive Officer and Derrick Sung, Chief Operating Officer and Chief Financial Officer. Earlier today, Pulmonx issued a press release announcing its financial results for the quarter ended June 30, 2026. A copy of the press release is available on the Pulmonx website.

Before we begin, I'd like to remind you that management will make statements during this call that include forward-looking statements within the meaning of federal securities laws, which are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. Any statements contained in this

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot